WHO classification of uterine tumors

Changed by Ayush Goel, 27 Sep 2014

Updates to Article Attributes

Body was changed:

Malignant neoplasms involving the uterus account for a significant proportion of all female cancers.

They can be classified as:

See also

  • -<p><strong>Malignant neoplasms involving the uterus</strong> account for a significant proportion of all female cancers.</p><p>They can be classified as</p><ul>
  • -<li>
  • -<a href="/articles/endometrial-carcinoma" title="Endometrial carcinoma">endometrial carcinoma</a> : commonest : &gt; 90% of all uterine malignancies<a href="/articles/missing" title="adenocarcinoma of the uterus" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(127,127,127); PADDING-TOP: 0px; TEXT-DECORATION: none"></a><ul>
  • -<li>
  • -<a href="/articles/adenocarcinoma-of-the-uterus" title="adenocarcinoma of the uterus">adenocarcinoma of the uterus</a> : commonest histological type : ~ 90%<a href="/articles/missing" title="adenocarcinoma of the uterus with squamous differentiation" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(127,127,127); PADDING-TOP: 0px; TEXT-DECORATION: none"></a>
  • -</li>
  • -<li>
  • -<a href="/articles/papillary-serous-carcinoma-of-the-uterus" title="papillary serous carcinoma of the uterus">papillary serous carcinoma of the uterus</a> : 5 - 1 %</li>
  • -<li>
  • -<a href="/articles/clear-cell-carcinoma-of-the-uterus" title="clear cell carcinoma of the uterus">clear cell carcinoma of the uterus</a> : ~ 1 - 5.5%</li>
  • -<li>
  • -<a href="/articles/adenosquamous-carcinoma-of-the-uterus" title="adenosquamous carcinoma of the uterus">adenosquamous carcinoma of the uterus </a>: ~ 2%</li>
  • -<li>
  • -<a href="/articles/adenocarcinoma-of-the-uterus-with-squamous-differentiation" title="adenocarcinoma of the uterus with squamous differentiation">adenocarcinoma of the uterus with squamous differentiation</a> : 0.25 - 0.5%</li>
  • -<li>
  • -<a href="/articles/missing" title="undifferentiated carcinoma of the endometrium" style="color: rgb(127, 127, 127); ">undifferentiated carcinoma of the endometrium</a><ul style="margin-top: 0px; margin-right: 0px; margin-bottom: 14px; margin-left: 40px; padding-right: 0px; padding-left: 0px; "><li><a href="/articles/missing" title="small cell undifferentied carcinoma of the endometrium" style="color: rgb(127, 127, 127); ">small cell undifferentied carcinoma of the endometrium</a></li></ul>
  • -</li>
  • -</ul>
  • -</li>
  • -<li>
  • -<a href="/articles/uterine-sarcoma" title="Uterine sarcoma">uterine sarcoma : </a>~ 1 - 6 % of all uterine malignancies<ul>
  • -<li>mixed<a href="/articles/malignant-mixed-mullerian-tumour-of-the-uterus" title="Malignant mixed mullerian tumour of the uterus" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(63,117,216); PADDING-TOP: 0px; TEXT-DECORATION: none"></a><ul>
  • -<li>
  • -<a href="/articles/malignant-mixed-mullerian-tumour-of-the-uterus" title="Malignant mixed mullerian tumour of the uterus" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(63,117,216); PADDING-TOP: 0px; TEXT-DECORATION: none">malignant mixed Mullerian tumour of the uterus</a> -</li>
  • -<li>
  • -<a href="/articles/carcinosarcoma-of-the-uterus" title="carcinosarcoma of the uterus">carcinosarcoma of the uterus</a> : ~ 50 - 70% of sarcomas</li>
  • -<li>mixed <a href="/articles/uterine-leiomyosarcoma" title="Uterine leiomyosarcoma" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(63,117,216); PADDING-TOP: 0px; TEXT-DECORATION: none">uterine leiomyosarcoma</a> and <a href="/articles/endometrial-stromal-sarcoma" title="endometrial stromal sarcoma" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(63,117,216); PADDING-TOP: 0px; TEXT-DECORATION: none">endometrial stromal sarcoma</a><a href="/articles/uterine-leiomyosarcoma" title="Uterine leiomyosarcoma" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(63,117,216); PADDING-TOP: 0px; TEXT-DECORATION: none"></a>
  • -</li>
  • -</ul>
  • -</li>
  • -<li>pure
  • -<ul>
  • -<li>
  • -<a href="/articles/uterine-leiomyosarcoma" title="Uterine leiomyosarcoma" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(63,117,216); PADDING-TOP: 0px; TEXT-DECORATION: none">uterine leiomyosarcoma</a> : ~ 33 - 50% of sarcomas</li>
  • -<li>
  • -<a href="/articles/endometrial-stromal-sarcoma" title="endometrial stromal sarcoma" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(63,117,216); PADDING-TOP: 0px; TEXT-DECORATION: none">endometrial stromal sarcoma</a> : ~ 10% of sarcomas <a href="/articles/missing" title="fibrosarcoma of the uterus" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(127,127,127); PADDING-TOP: 0px; TEXT-DECORATION: none"></a>
  • -</li>
  • -<li>
  • -<a href="/articles/fibrosarcoma-of-the-uterus" title="fibrosarcoma of the uterus">fibrosarcoma of the uterus</a> : rare<a href="/articles/missing" title="rhabdomyosarcoma of the uterus" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(127,127,127); PADDING-TOP: 0px; TEXT-DECORATION: none"></a>
  • -</li>
  • -<li>
  • -<a href="/articles/rhabdomyosarcoma-of-the-uterus" title="rhabdomyosarcoma of the uterus">rhabdomyosarcoma of the uterus</a> : rare<a href="/articles/missing" title="liposarcoma of the uterus" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(127,127,127); PADDING-TOP: 0px; TEXT-DECORATION: none"></a>
  • -</li>
  • -<li>
  • -<a href="/articles/liposarcoma-of-the-uterus" title="liposarcoma of the uterus">liposarcoma of the uterus</a> : rare<a href="/articles/missing" title="angiosarcoma of the uterus" style="PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px; COLOR: rgb(127,127,127); PADDING-TOP: 0px; TEXT-DECORATION: none"></a>
  • -</li>
  • -<li>
  • -<a href="/articles/angiosarcoma-of-the-uterus" title="angiosarcoma of the uterus">angiosarcoma of the uterus</a> : rare</li>
  • -</ul>
  • -</li>
  • -</ul>
  • -</li>
  • -<li>
  • -<a href="/articles/gestational-trophoblastic-tumours" title="gestational trophoblastic tumours">gestational trophoblastic tumours</a><ul><li><a href="/articles/choriocarcinoma-of-uterus" title="choriocarcinoma of uterus">choriocarcinoma of uterus</a></li></ul>
  • -</li>
  • -<li>
  • -<a href="/articles/uterine-lymphoma" title="uterine lymphoma">uterine lymphoma </a>: 
  • -<ul>
  • -<li><a href="/articles/primary-uterine-lymphoma" title="primary uterine lymphoma">primary uterine lymphoma</a></li>
  • -<li><a href="/articles/secondary-involvment-of-the-uterus-by-lymphoma" title="secondary involvment of the uterus by lymphoma">secondary involvement of the uterus by lymphoma</a></li>
  • -</ul>
  • -</li>
  • -<li>malignancies that are not of the uterus, but can involve the uterus
  • -<ul>
  • -<li>invasion of the uterus by
  • -<ul>
  • -<li><a href="/articles/cervical-carcinoma" title="cervical carcinoma">cervical carcinoma</a></li>
  • -<li><a href="/articles/primary-vaginal-carcinoma" title="Vaginal carcinoma">vaginal carcinoma</a></li>
  • -<li><a href="/articles/primary-fallopian-tube-carcinoma" title="Tubal carcinoma">tubal carcinoma</a></li>
  • -<li><a href="/articles/colorectal-carcinoma" title="Colorectal carcinoma">colorectal carcinoma</a></li>
  • -<li><a href="/articles/cancers-from-the-bladder" title="cancers from the bladder">cancers from the bladder</a></li>
  • -</ul>
  • -</li>
  • -</ul>
  • -</li>
  • -<li>metastases to the uterus from a non gynaecolological malignancy (rare but if it does occur, it is most commonly breast or stomach <sup>3</sup>)</li>
  • -</ul><h4>See also</h4><ul style="padding-right: 0px; padding-left: 0px; margin: 0px 0px 14px 40px; font-family: Helvetica, Arial, sans-serif;"><li style="padding: 0px; margin: 0px;"><a href="/articles/missing" title="uterine smooth muscle tumours of uncertain malignant potential" style="padding: 0px; margin: 0px; color: rgb(127, 127, 127);">uterine smooth muscle tumours of uncertain malignant potential</a></li></ul>
  • +<p><strong>Malignant neoplasms involving the uterus</strong> account for a significant proportion of all female cancers.</p><p>They can be classified as:</p><ul>
  • +<li>
  • +<a href="/articles/endometrial-carcinoma">endometrial carcinoma</a> : commonest: &gt;90% of all uterine malignancies<ul>
  • +<li>
  • +<a href="/articles/adenocarcinoma-of-the-uterus">adenocarcinoma of the uterus</a>: commonest histological type, ~90%</li>
  • +<li>
  • +<a href="/articles/papillary-serous-carcinoma-of-the-uterus">papillary serous carcinoma of the uterus</a>: 5-1%</li>
  • +<li>
  • +<a href="/articles/clear-cell-carcinoma-of-the-uterus">clear cell carcinoma of the uterus</a>: ~1-5.5%</li>
  • +<li>
  • +<a href="/articles/adenosquamous-carcinoma-of-the-uterus">adenosquamous carcinoma of the uterus</a>: ~2%</li>
  • +<li>
  • +<a href="/articles/adenocarcinoma-of-the-uterus-with-squamous-differentiation">adenocarcinoma of the uterus with squamous differentiation</a>: 0.25-0.5%</li>
  • +<li>
  • +<a href="/articles/missing">undifferentiated carcinoma of the endometrium</a><ul><li><a href="/articles/missing">small cell undifferentied carcinoma of the endometrium</a></li></ul>
  • +</li>
  • +</ul>
  • +</li>
  • +<li>
  • +<a href="/articles/uterine-sarcoma">uterine sarcoma: </a>~1-6% of all uterine malignancies<ul>
  • +<li>mixed<ul>
  • +<li><a href="/articles/malignant-mixed-mullerian-tumour-of-the-uterus">malignant mixed Mullerian tumour of the uterus</a></li>
  • +<li>
  • +<a href="/articles/carcinosarcoma-of-the-uterus">carcinosarcoma of the uterus</a>: ~50-70% of sarcomas</li>
  • +<li>mixed <a href="/articles/uterine-leiomyosarcoma">uterine leiomyosarcoma</a> and <a href="/articles/endometrial-stromal-sarcoma">endometrial stromal sarcoma</a>
  • +</li>
  • +</ul>
  • +</li>
  • +<li>pure<ul>
  • +<li>
  • +<a href="/articles/uterine-leiomyosarcoma">uterine leiomyosarcoma</a>: ~33-50% of sarcomas</li>
  • +<li>
  • +<a href="/articles/endometrial-stromal-sarcoma">endometrial stromal sarcoma</a>: ~10% of sarcomas </li>
  • +<li>
  • +<a href="/articles/fibrosarcoma-of-the-uterus">fibrosarcoma of the uterus</a>: rare</li>
  • +<li>
  • +<a href="/articles/rhabdomyosarcoma-of-the-uterus">rhabdomyosarcoma of the uterus</a>: rare</li>
  • +<li>
  • +<a href="/articles/liposarcoma-of-the-uterus">liposarcoma of the uterus</a>: rare</li>
  • +<li>
  • +<a href="/articles/angiosarcoma-of-the-uterus">angiosarcoma of the uterus</a>: rare</li>
  • +</ul>
  • +</li>
  • +</ul>
  • +</li>
  • +<li>
  • +<a href="/articles/gestational-trophoblastic-tumours">gestational trophoblastic tumours</a><ul><li><a href="/articles/choriocarcinoma-of-uterus">choriocarcinoma of uterus</a></li></ul>
  • +</li>
  • +<li>
  • +<a href="/articles/uterine-lymphoma">uterine lymphoma </a><ul>
  • +<li><a href="/articles/primary-uterine-lymphoma">primary uterine lymphoma</a></li>
  • +<li><a href="/articles/secondary-involvment-of-the-uterus-by-lymphoma">secondary involvement of the uterus by lymphoma</a></li>
  • +</ul>
  • +</li>
  • +<li>malignancies that are not of the uterus, but can involve the uterus<ul><li>invasion of the uterus by<ul>
  • +<li><a href="/articles/cervical-carcinoma">cervical carcinoma</a></li>
  • +<li><a href="/articles/primary-vaginal-carcinoma">vaginal carcinoma</a></li>
  • +<li><a href="/articles/primary-fallopian-tube-carcinoma">tubal carcinoma</a></li>
  • +<li><a href="/articles/colorectal-carcinoma">colorectal carcinoma</a></li>
  • +<li><a href="/articles/cancers-from-the-bladder">cancers from the bladder</a></li>
  • +</ul>
  • +</li></ul>
  • +</li>
  • +<li>metastases to the uterus from a non gynaecolological malignancy (rare but if it does occur, it is most commonly breast or stomach <sup>3</sup>)</li>
  • +</ul><h4>See also</h4><ul><li><a href="/articles/missing">uterine smooth muscle tumours of uncertain malignant potential</a></li></ul>
Images Changes:

Image 1 CT (C+ portal venous phase) ( update )

Caption was changed:
Case 1: leiomyosarcoma of the uterus

Image 2 MRI (T2) ( update )

Caption was changed:
Case 2: malignanct mixed Mullerian tumour

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.